Edition:
United States

Integra Lifesciences Holdings Corp (IART.OQ)

IART.OQ on NASDAQ Stock Exchange Global Select Market

58.97USD
4:00pm EDT
Change (% chg)

$-0.61 (-1.02%)
Prev Close
$59.58
Open
$59.42
Day's High
$60.01
Day's Low
$58.34
Volume
301,676
Avg. Vol
333,141
52-wk High
$67.43
52-wk Low
$43.04

Chart for

About

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including... (more)

Overall

Beta: 0.60
Market Cap(Mil.): $5,279.01
Shares Outstanding(Mil.): 85.13
Dividend: --
Yield (%): --

Financials

  IART.OQ Industry Sector
P/E (TTM): 42.06 37.48 30.17
EPS (TTM): 1.42 -- --
ROI: 4.65 14.29 12.67
ROE: 10.13 17.46 14.86

BRIEF-Integra Lifesciences Prices Public Offering Of Common Stock

* INTEGRA LIFESCIENCES PRICES PUBLIC OFFERING OF COMMON STOCK

May 09 2018

BRIEF-Integra LifeSciences Announces Proposed Public Offering Of Common Stock

* INTEGRA LIFESCIENCES ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

May 09 2018

BRIEF-Integra Lifesciences Announces Amendment And Extension Of Credit Facility

* INTEGRA LIFESCIENCES ANNOUNCES AMENDMENT AND EXTENSION OF CREDIT FACILITY

May 07 2018

BRIEF-Integra Lifesciences Reports Q1 Adjusted Earnings Per Share $0.58

* INTEGRA LIFESCIENCES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

Apr 25 2018

BRIEF-Integra LifeSciences Says CEO's 2017 Compensation Was $7.1 Mln

* INTEGRA LIFESCIENCES HOLDINGS CORP SAYS CEO PETER J. ARDUINI'S 2017 TOTAL COMPENSATION WAS $7.1 MILLION VERSUS $7 MILLION IN 2016 – SEC FILING ‍​ Source: (https://bit.ly/2HdNFnd) Further company coverage:

Apr 06 2018

BRIEF-Integra Lifesciences Holdings Reports Q4 EPS Of $0.56

* INTEGRA LIFESCIENCES REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS

Feb 27 2018

BRIEF-Integra Lifesciences Q4 Adjusted Earnings Per Share $0.64

* INTEGRA LIFESCIENCES REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS

Feb 27 2018

Earnings vs. Estimates